{"code":"E08.359","type":"category","title":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":["the underlying condition, such as:","congenital rubella (P35.0)","Cushing's syndrome (E24.-)","cystic fibrosis (E84.-)","malignant neoplasm (C00-C96)","malnutrition (E40-E46)","pancreatitis and other diseases of the pancreas (K85-K86.-)"],"excludes1":["drug or chemical induced diabetes mellitus (E09.-)","gestational diabetes (O24.4-)","neonatal diabetes mellitus (P70.2)","postpancreatectomy diabetes mellitus (E13.-)","postprocedural diabetes mellitus (E13.-)","secondary diabetes mellitus NEC (E13.-)","type 1 diabetes mellitus (E10.-)","type 2 diabetes mellitus (E11.-)"],"excludes2":[],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":false,"billableFy2027":false},"sibling_codes":["E08.3591","E08.3592","E08.3593","E08.3599"],"inclusionTerms":[],"sibling_titles":{"code":"E08.3599","title":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye","isBillable":true},"useAdditionalCode":["code to identify control using:","injectable non-insulin antidiabetic drugs (Z79.85)","insulin (Z79.4)","oral antidiabetic drugs (Z79.84)","oral hypoglycemic drugs (Z79.84)"],"clinicalDefinition":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema is a non-billable ICD-10-CM category code (E08.359). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); postpancreatectomy diabetes mellitus (E13.-); postprocedural diabetes mellitus (E13.","officialDefinition":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema is a non-billable ICD-10-CM category code (E08.359). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); postpancreatectomy diabetes mellitus (E13.-); postprocedural diabetes mellitus (E13.-); secondary diabetes mellitus NEC (E13.-); type 1 diabetes mellitus (E10.-); type 2 diabetes mellitus (E11.-). Code first: the underlying condition, such as:; congenital rubella (P35.0); Cushing's syndrome (E24.-); cystic fibrosis (E84.-); malignant neoplasm (C00-C96); malnutrition (E40-E46); pancreatitis and other diseases of the pancreas (K85-K86.-). Use additional code: code to identify control using:; injectable non-insulin antidiabetic drugs (Z79.85); insulin (Z79.4); oral antidiabetic drugs (Z79.84); oral hypoglycemic drugs (Z79.84). 7th character: One of the following 7th characters is to be assigned to codes in subcategory E08.35 to designate laterality of the disease:.","seventhCharacterInstructions":["One of the following 7th characters is to be assigned to codes in subcategory E08.35 to designate laterality of the disease:"],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}